Forteris Wealth Management Invests $2.65M in Eli Lilly

The institutional investor added the pharmaceutical giant to its portfolio in Q4.

Apr. 20, 2026 at 7:49am

Got story updates? Submit your updates here. ›

An extreme close-up of a complex network of shiny metal gears and machinery, conceptually representing the institutional financial systems that support major pharmaceutical companies like Eli Lilly.Forteris Wealth Management's substantial investment in Eli Lilly reflects the pharmaceutical giant's financial strength and institutional backing.Indianapolis Today

Forteris Wealth Management Inc. purchased a new position in Eli Lilly and Company (NYSE:LLY) in the fourth quarter, according to a recent SEC filing. The firm invested approximately $2,654,000 to acquire 2,470 shares of the company's stock, making Eli Lilly its 15th largest holding.

Why it matters

This investment highlights the continued confidence of institutional investors in Eli Lilly's growth potential and market leadership in the pharmaceutical industry. Forteris Wealth Management's decision to add Eli Lilly to its portfolio reflects the stock's strong performance and the firm's belief in the company's long-term prospects.

The details

Forteris Wealth Management Inc. purchased the Eli Lilly shares in the fourth quarter of 2025. The investment represents approximately 2.6% of the firm's total portfolio. A number of other institutional investors also recently made changes to their Eli Lilly holdings, with some increasing their positions and others initiating new stakes in the company.

  • Forteris Wealth Management Inc. acquired the Eli Lilly shares in Q4 2025.
  • Eli Lilly stock opened at $926.90 on Monday, April 20, 2026.

The players

Forteris Wealth Management Inc.

An institutional investment firm that manages a portfolio of stocks, bonds, and other assets on behalf of its clients.

Eli Lilly and Company

A global pharmaceutical company that researches, develops, manufactures, and commercializes a broad range of medicines and therapies for patients worldwide.

Got photos? Submit your photos here. ›

The takeaway

Forteris Wealth Management's investment in Eli Lilly reflects the pharmaceutical company's strong market position and growth potential, as institutional investors continue to see value in the stock despite broader market fluctuations.